Derniers articles listés par PubMed sur les maladies rares hépato-biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
> création: PhDu, albi, le 15/10/2013 > rédaction: PhDu, albi, le 15/10/2013 > mise à jour : PhDu, albi le 27/02/2025
Actualité de la recherche sur les maladies rares hépato-biliaires
- IgA Nephropathy With a Membranoproliferative Glomerulonephritis Pattern Associated With Autoimmune Hepatitis: A Case Reportpar Hiroya Adachi le 28 avril 2026 à 10 h 00
Cirrhosis is a known cause of secondary IgA nephropathy (IgAN), often presenting with a membranoproliferative glomerulonephritis (MPGN) pattern and poor renal outcomes. We report a case of IgAN with an MPGN pattern associated with autoimmune hepatitis (AIH) in a 74-year-old woman. Although the patient had liver cirrhosis, her AIH was in clinical remission following prior corticosteroid therapy. She presented with nephrotic-range proteinuria and lower leg edema. Renal biopsy confirmed IgAN with...
- Severe Hepatic Iron Overload and Cirrhosis in an HFE C282Y Heterozygote With Autoimmune Hepatitis: A Case of Genotype-Phenotype Discordancepar Rodrigo Furlan Silva Fabri le 27 avril 2026 à 10 h 00
Hereditary hemochromatosis is a disorder of iron metabolism characterized by increased intestinal iron absorption and progressive parenchymal iron deposition, most commonly associated with homozygous mutations in the HFE gene. In contrast, heterozygous carriers of HFE mutations are generally considered to have low clinical penetrance and are not expected to develop clinically significant iron overload or advanced liver disease. However, iron homeostasis may be substantially altered in the...
- Intraductal Papillary Neoplasm With Associated Invasive Cholangiocarcinoma and Biliary Intraepithelial Neoplasia in Primary Sclerosing Cholangitis: A Case Reportpar Ziad Letaïef le 27 avril 2026 à 10 h 00
Intraductal papillary neoplasm of the bile duct (IPNB) is a biliary epithelial tumor that represents a recognized precursor lesion of cholangiocarcinoma. We report the case of a 60-year-old woman who presented to the emergency department with acute abdominal pain. A CT scan performed for suspected nephrolithiasis incidentally revealed an irregular hypodense lesion in segment VI of the liver with associated intrahepatic bile duct dilatation. Further evaluation with MRI and magnetic resonance...
- Pediatric Autoimmune Sclerosing Cholangitis: Diagnostic and Therapeutic Challengespar Raisa-Maria Sucaciu le 27 avril 2026 à 10 h 00
CONCLUSIONS: This case highlights the complexity of managing pediatric patients with multiple autoimmune diseases. The necessary combination of immunosuppressive therapies may lead to significant adverse effects and further complicate disease progression. Moreover, psychological components play a crucial role in treatment compliance and therapeutic success, emphasizing the need for an integrated approach that includes specialized psychological support.
- Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitispar Yavuz Emre Parlar le 27 avril 2026 à 10 h 00
CONCLUSION: Cystic dilatation appears to be a clinically relevant prognostic feature in patients with primary sclerosing cholangitis, however, confirmation in larger studies is warranted.
- Prevalence and clinical impact of hepatic steatosis on autoimmune liver disease: A systematic review and meta-analysispar Jarell Jie-Rae Tan le 27 avril 2026 à 10 h 00
CONCLUSIONS: AIH patients with concomitant HS had worse outcomes than those without HS; whereas HS did not influence the clinical outcomes in patients with PBC. Future research evaluating the impact of HS on PSC and overlap syndrome is much needed.
- Autoimmune liver diseases and overlap syndromes in children with inflammatory bowel diseasespar Giovanna Fernanda Vazzana le 26 avril 2026 à 10 h 00
CONCLUSION: Pediatric IBD-associated AILDs represent a heterogeneous and high-risk group of disorders. Multimodal diagnostic strategies and immunosuppressive therapy are central to management; however, effective treatments for PSC remain lacking, highlighting major unmet clinical needs.
- Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysispar Bachviet Nguyen le 26 avril 2026 à 10 h 00
CONCLUSIONS: PBC is consistently associated with higher waitlist mortality risk compared with PSC, AIH, and ALD, highlighting potential under-prioritization of this condition for liver transplant. Allocation policies may consider disease-specific exceptions or prognostic models tailored to AILDs to reduce waitlist mortality disparities.
- Comment on "Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan"par Qi Fan le 25 avril 2026 à 10 h 00
No abstract
- Therapeutic Repurposing of Avanafil Against Lipopolysaccharide-induced Depression and Autoimmune Hepatitis: Gut-brain-liver Axis Orchestration Via Regulation of TLR4/NF-kappaB/IDO and Nrf2/HO-1 Pathwayspar Kawther Magdy Ibrahim le 25 avril 2026 à 10 h 00
Emerging evidence has highlighted the gut-brain axis as a critical mediator in the pathogenesis of both major depressive disorder (MDD) and autoimmune hepatitis (AIH), where systemic inflammation and gut barrier dysfunction play pivotal roles. This study investigated the therapeutic potential of avanafil (AVA), a selective phosphodiesterase-5 inhibitor (PDE5I), in a lipopolysaccharide (LPS)-induced rat model that mimics inflammation-driven MDD and AIH. LPS administration significantly impaired...
- Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysispar Ruben J Colman le 24 avril 2026 à 10 h 00
CONCLUSIONS: While musculoskeletal manifestations are common, fewer than 5% of pIBD patients experience ophthalmological, dermatological, and liver IM-EIMs. The small number of studies resulted in significant methodological and statistical heterogeneity. Multicenter collaborative efforts are needed to systematically describe the epidemiology of IM-EIMs in pIBD.
- Hepatotoxicity Associated with Labetalol Use: A Case Report with Systematic Review and Disproportionality Analysis Using FAERSpar Emma D Hendriksen le 24 avril 2026 à 10 h 00
Labetalol is widely prescribed as a first-line antihypertensive in pregnancy; however, rare but potentially severe idiosyncratic hepatotoxicity has been reported, with a disproportionately strong reporting signal for liver injury relative to other β-blockers. In this report, a fatal case is described in which mild initial symptoms rapidly progressed to fulminant hepatocellular injury and acute liver failure within days, underscoring the importance of early recognition of drug-induced liver...
- Adolescent with severe liver disease and positive autoantibodies: when Wilson's disease presents as autoimmune hepatitispar Gabriela Modrak le 24 avril 2026 à 10 h 00
Wilson's disease (WD) is an autosomal recessive disorder caused by mutations in the ATP7B gene, leading to impaired copper metabolism. Its clinical presentation is heterogeneous and may mimic autoimmune hepatitis (AIH), making timely diagnosis challenging, particularly in adolescents with severe liver disease of unknown origin. A retrospective descriptive study was conducted based on the medical record review of a patient diagnosed with WD and treated at a university referral hospital. The study...
- Shared pathogenic mechanisms between systemic lupus erythematosus and autoimmune hepatitis: A unified view of autoimmune convergencepar Wu Yechen le 24 avril 2026 à 10 h 00
CONCLUSION: SLE and AIH represent overlapping entities along a unified autoimmune spectrum, driven by shared genetic susceptibility, convergent immune dysregulation, and microbial influences. This review advances an integrated immunological framework that bridges systemic and organ-specific autoimmunity, underscores the pivotal role of innate immunity and gut-liver crosstalk, and provides a mechanistic rationale for cross-disease therapeutic strategies targeting these common pathways.
- Dendriform pulmonary ossification in fibrosing interstitial lung disease with primary biliary cholangitispar Tomoyuki Ogata le 24 avril 2026 à 10 h 00
Dendriform pulmonary ossification (DPO) is a rare condition characterised by branching bone formation within the lung parenchyma, often associated with fibrotic interstitial lung disease (ILD). We report an asymptomatic man in his 80s with primary biliary cholangitis who presented with bilateral lower-lobe fibrosis and subpleural micronodules on high-resolution CT, initially suggesting granulomatous ILD. Transbronchial lung cryobiopsy revealed fibrosis with intra-alveolar ossification and...
- Double-barreled drug-induced liver injury and the unmasking of latent primary biliary cholangitis: A case of amoxicillin-clavulanate and warfarin interactionpar Omkolsoum Alhaddad le 24 avril 2026 à 10 h 00
CONCLUSION: This case illustrates a multifactorial liver injury wherein amoxicillin-clavulanate served as the primary hepatotoxin, with possible warfarin-related hepatotoxicity and coagulopathy superimposed on latent PBC. It emphasizes the need for vigilance when prescribing interacting with or hepatotoxic agents to patients on chronic anticoagulation. The case further demonstrates the supportive-but not definitive-role of RUCAM in polypharmacy-related DILI assessment, reinforcing the primacy of...
- Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitispar Yunguan Wang le 23 avril 2026 à 10 h 00
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts, yet the cellular crosstalk driving periductal fibrosis remains poorly defined. This study applied a multi-omics approach integrating spatial transcriptomics, RNA-seq, and proteomics to characterize fibrotic periductal regions and their cell-cell communications. Macrophages (MP) subsets, including monocyte-drived-(Mo)MP and...
- A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reactionpar Mariana Amaral Raposo le 23 avril 2026 à 10 h 00
CONCLUSIONS: Gli1 demarcates a subpopulation of fibroblasts that play a key role in the wound healing process combining portal fibrosis and ductular reaction notably in biliary diseases.
- Clinicopathological features of non-cirrhotic portal fibrosis in primary biliary cholangitis: a 15-year experience at a tertiary referral centerpar Xiuhong Wang le 23 avril 2026 à 10 h 00
CONCLUSION: This study identifies a high prevalence of NCPF in early PBC. Its association with greater biochemical activity and specific vascular histopathological alterations suggests that the presence of NCPF may delineate a more active PBC phenotype, offering potential value for early risk assessment.
- Graves' disease and autoimmune hepatitis overlap syndrome with coincidental simultaneous presentation in a pediatric patientpar Grażyna Waśka le 23 avril 2026 à 10 h 00
CONCLUSIONS: In pediatric patients presenting with GD-associated liver dysfunction, AIH should be considered as a potential comorbidity, warranting vigilance in patients with hyperthyroidism and elevated transaminase levels.
